⌘K

Login Start Free

Home/Filings/4/0001171000-15-000074

4//SEC Filing

Nexvet Biopharma plc 4

Accession 0001171000-15-000074

CIK 0001618561operating

View on SEC.gov Company Profile

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 2:54 PM ET

Size

5.5 KB

Accession

0001171000-15-000074

Insider Transaction Report

Form 4

Period: 2015-09-03

Nexvet Biopharma plcNVET

Director

Transactions

Award
Restricted Share Units
2015-09-03+3,600→ 3,600 total
Exercise: $0.13From: 2016-07-01Exp: 2020-07-01→ Ordinary Shares (3,600 underlying)

Footnotes (1)

[F1]3,600 of the Restricted Share Units shall vest and become convertible on 7/1/16, subject to payment of the nominal value per share to Issuer within 30 days of vesting.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Nexvet Biopharma plc

CIK 0001618561

Entity typeoperating

IncorporatedIreland

Related Parties

1

filerCIK 0001618561

Filing Metadata

Form type: 4
Filed: Sep 7, 8:00 PM ET
Accepted: Sep 8, 2:54 PM ET
Size: 5.5 KB

View on SEC.gov